Ohio State University scientists develop peptides that could block SARS-CoV-2 virus from entering human body

Ohio State University scientists have developed a protein fragments that will help people avoid from getting COVID-19 if they come in contact with the virus. Severe acute respiratory syndrome aka SARS-CoV-2 binds to a receptor protein on the targeted cell’s surface known as angiotensin-converting enzyme 2 through its receptor binding domains of red blood cells.

According to the study published in the Jan issue of Bioconjugate Chemistry journal, Scientist have developed, designed and tested peptides which is a replica of ACE2 receptor and it will convince SARS-CoV-2 to bind with them and will block the virus from getting inside the cell.

Ohio State University scientist are looking to deliver the peptides in the form of nasal spray to block the circulation of SARS-CoV-2 access points that will prevent their entry into target cells. This comes as a big step as the world is struggling to return to the normalcy after severely being hit with the global pandemic.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More